What does PMS MEDICAL do?

PMS MEDICAL is registered with the CBE as active in: Activiteiten van holdings. Public Limited, started on 9 March 1999, 1 establishment.

What is the address of PMS MEDICAL?

The registered office of PMS MEDICAL is located at Middenweg 20, 3930 Hamont-Achel.

Is PMS MEDICAL still active?

Yes. According to the CBE (30 October 2026) PMS MEDICAL is active, legal situation “Normale toestand”, started on 9 March 1999.

Is PMS MEDICAL registered on Peppol?

Yes, PMS MEDICAL is registered on the Peppol network with ID 0208:0465490132.

What is the enterprise number of PMS MEDICAL?

The enterprise number of PMS MEDICAL is BE0465490132.

When was PMS MEDICAL founded?

PMS MEDICAL was founded on 9 March 1999.

Who are the directors of PMS MEDICAL?

According to the 2025 annual accounts, the directors of PMS MEDICAL are: Cimco Consult BV.

Is PMS MEDICAL a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 9 March 1999; 4 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did PMS MEDICAL make in 2025?

PMS MEDICAL posted a profit after taxes of € 8,140 in financial year 2025.

What is the revenue of PMS MEDICAL?

As a small company, PMS MEDICAL is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 29,774.

PMS MEDICAL (Public Limited) - Hamont-Achel

Dossier PMS MEDICAL, printed on 30 October 2026 from databakkes.be/en/0465490132/pms-medical. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 16 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

PMS MEDICAL from Hamont-Achel, company number BE0465490132, closed financial year 2025 with a result of € 8,140 after tax. For that financial year PMS MEDICAL recorded a gross margin of € 29,774 and equity of € 145,174. Compared with financial year 2024, the result moved from € 11,819 to € 8,140. The company is profitable. The company holds a healthy buffer. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on February 26, 2026.

What it is worth Healthy

€ 145,174

▼ 42% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 8,140

▼ 31% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 7,781

▲ € 7,045 vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 114,143 paid out

More than the year’s profit went to the shareholders; reserves fell.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 782

▲ 3% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 9,640

▲ 116% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 28,637 Gross margin 2022: € 28,637 First fiscal year in the series	€ 30,953 Gross margin 2023: € 30,953 ▲ 8% vs 2022 (€ 28,637) Favourable step	€ 30,992 Gross margin 2024: € 30,992 Unchanged (€ 30,953) Favourable step	€ 29,774 Gross margin 2025: € 29,774 ▼ 4% vs 2024 (€ 30,992) Unfavourable step	▼ 4%
Profit after taxes	€ 14,300 Profit after taxes 2022: € 14,300 First fiscal year in the series	€ 16,411 Profit after taxes 2023: € 16,411 ▲ 15% vs 2022 (€ 14,300) Favourable step	€ 11,819 Profit after taxes 2024: € 11,819 ▼ 28% vs 2023 (€ 16,411) Unfavourable step	€ 8,140 Profit after taxes 2025: € 8,140 ▼ 31% vs 2024 (€ 11,819) Unfavourable step	▼ 31%
Equity	€ 222,945 Equity 2022: € 222,945 First fiscal year in the series	€ 239,357 Equity 2023: € 239,357 ▲ 7% vs 2022 (€ 222,945) Favourable step	€ 251,176 Equity 2024: € 251,176 ▲ 5% vs 2023 (€ 239,357) Favourable step	€ 145,174 Equity 2025: € 145,174 ▼ 42% vs 2024 (€ 251,176) Unfavourable step	▼ 42%
Total debts	€ 191,442 Total debts 2022: € 191,442 First fiscal year in the series	€ 178,135 Total debts 2023: € 178,135 ▼ 7% vs 2022 (€ 191,442) Favourable step	€ 178,956 Total debts 2024: € 178,956 Unchanged (€ 178,135) Unfavourable step	€ 289,518 Total debts 2025: € 289,518 ▲ 62% vs 2024 (€ 178,956) Unfavourable step	▲ 62%
Cash	€ 8,538 Cash 2022: € 8,538 First fiscal year in the series	€ 6,898 Cash 2023: € 6,898 ▼ 19% vs 2022 (€ 8,538) Unfavourable step	€ 736 Cash 2024: € 736 ▼ 89% vs 2023 (€ 6,898) Unfavourable step	€ 7,781 Cash 2025: € 7,781 ▲ € 7,045 vs 2024 (€ 736) Favourable step	▲ € 7,045
Retained profit	€ 160,945 Retained profit 2022: € 160,945 First fiscal year in the series	€ 177,357 Retained profit 2023: € 177,357 ▲ 10% vs 2022 (€ 160,945) Favourable step	€ 189,176 Retained profit 2024: € 189,176 ▲ 7% vs 2023 (€ 177,357) Favourable step	€ 83,174 Retained profit 2025: € 83,174 ▼ 56% vs 2024 (€ 189,176) Unfavourable step	▼ 56%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 0 Dividend 2024: € 0 Unchanged (€ 0) Unchanged	€ 114,143 Dividend 2025: € 114,143 Unchanged (€ 0) Unchanged
Bank debt	€ 19,729 Bank debt 2022: € 19,729 First fiscal year in the series	€ 6,784 Bank debt 2023: € 6,784 ▼ 66% vs 2022 (€ 19,729) Favourable step	€ 4,718 Bank debt 2024: € 4,718 ▼ 30% vs 2023 (€ 6,784) Favourable step	€ 0 Bank debt 2025: € 0 ▼ 100% vs 2024 (€ 4,718) Favourable step	▼ 100%
Balance sheet total	€ 414,387 Balance sheet total 2022: € 414,387 First fiscal year in the series	€ 417,492 Balance sheet total 2023: € 417,492 ▲ 1% vs 2022 (€ 414,387) Unchanged	€ 430,132 Balance sheet total 2024: € 430,132 ▲ 3% vs 2023 (€ 417,492) Unchanged	€ 434,692 Balance sheet total 2025: € 434,692 ▲ 1% vs 2024 (€ 430,132) Unchanged	▲ 1%

Key figures of PMS MEDICAL, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 January 2027.

What happened to PMS MEDICAL?

What happened at PMS MEDICAL in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Feb 26, 2026 New annual accounts for financial year 2025: profit of € 8,140 (▼ 31% vs 2024). filed late Source: NBB ↗
Jun 18, 1999 New establishment in Hamont-Achel. KBO
Mar 9, 1999 Start of the company according to the CBE. KBO

In short

From € 14,300 profit in 2022 to € 8,140 profit in 2025.

Paid € 23,342 in corporate taxes since 2022.

Best year ever: 2023, with € 16,411 profit.

Paid out € 114,143 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Cimco Consult BV

PMS MEDICAL

Mondomed 99.6%

Mondomed Italia S.r.l 94%

Behind PMS MEDICAL is Cimco Consult BV. It owns 99.6% of Mondomed and 94% of Mondomed Italia S.r.l itself.

Directors

According to the 2025 annual accounts

Cimco Consult BV

Director · represented by Pasquale Cimmino

Also active at: MONDOMED

Establishments

Establishment units

Physical locations of this company

Registered office

Middenweg 20

3930 Hamont-Achel

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

MONDOMED same network

€ 1.9 million gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0465.490.132

VAT number

BE 0465.490.132

Registered office

Middenweg 20, 3930 Hamont-Achel

Names & denominations

PMS MEDICAL

Enterprise type

Rechtspersoon

Legal form

Public limited company

Legal situation

Normale toestand

Start date

9 March 1999

Peppol

Active · Active since 18 Aug 2025

Activities · NACE

Activiteiten van holdings

Holdings

Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies

Verhuur en exploitatie van eigen of geleased residentieel onroerend goed, exclusief sociale woningen

Verhuur en exploitatie van eigen of geleased niet-residentieel onroerend goed, exclusief terreinen

Activiteiten van hoofdkantoren

Handel in eigen onroerend goed

Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering

View on CBE Public ↗ Annual accounts (NBB) ↗

PMS MEDICAL

Warning lights

Financials

What happened to PMS MEDICAL?

Management

Directors

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions